Skip to main content

Advertisement

Log in

Unusual histologic and clinical variants of melanoma: Implications for therapy

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Unusual histologic variants of melanoma may be problematic to the histopathologist. Several of these variants are sufficiently rare that their biologic behavior remains obscure. As identification of some of these melanoma subtypes has specific implications for the therapeutic approach, and as some may mimic other forms of epithelial or mesenchymal neoplasia, their recognition is key to patient management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Conley J, Lattes R, Orr W: Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971, 28:914–936.

    Article  PubMed  CAS  Google Scholar 

  2. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL: Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer 1995, 75:478–494.

    Article  PubMed  CAS  Google Scholar 

  3. Quinn MJ, Crotty KA, Thompson JF, et al.: Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998, 83:1128–1135.

    Article  PubMed  CAS  Google Scholar 

  4. Smithers BM, McLeod GR, Little JH: Desmoplastic melanoma: patterns of recurrence. World J Surg 1992, 16:186–190.

    Article  PubMed  CAS  Google Scholar 

  5. Bruijn JA, Mihm MC Jr, Barnhill RL: Desmoplastic melanoma. Histopathology 1992, 20:197–205.

    Article  PubMed  CAS  Google Scholar 

  6. Crowson AN, Magro CM, Mihm MC Jr: The Melanocytic Proliferations: a Comprehensive Textbook of Pigmented Lesions. New York: John Wiley; 2001:281–397.

    Google Scholar 

  7. Moreno A, Lamarca J, Martinez R, Guix M. Osteoid and bone formation in desmoplastic malignant melanoma. J Cutan Pathol 1986, 13(2):128–134.

    Article  PubMed  CAS  Google Scholar 

  8. Hawkins WG, Busam KJ, Ben-Porat L et al.: Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol 2005, 12:197–199.

    Article  Google Scholar 

  9. Busam KJ, Kucukgol D, Sato E, et al.: Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers. Am J Surg Pathol 2005, 29:400–406.

    Article  PubMed  Google Scholar 

  10. Winnepenninckx V, De Vos R, Stas M, van den Ooord JJ: New phenotypic and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma. Appl Immunohistochem Mol Morphol 2003; 11:319–325.

    PubMed  Google Scholar 

  11. Busam KJ, Iversen K, Coplan KC, Jungbluth AA: Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S100 protein, gp100, and tyrosinase in desmoplastic melanoma. Am J Surg Pathol 2001, 25:197–204.

    Article  PubMed  CAS  Google Scholar 

  12. Sagebiel RW: Unusual variants of melanoma: Fact or fiction? Semin Oncol 1996, 23:703–708.

    PubMed  CAS  Google Scholar 

  13. Schmoeckel C, Castro CE, Braun-Falco O: Nevoid malignant melanoma. Arch Derm Res 1985, 277:362–369.

    Article  PubMed  CAS  Google Scholar 

  14. Levene A: On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol 1980, 33:101–124.

    Article  PubMed  CAS  Google Scholar 

  15. Zembowicz A, McCusker M, Chiarelli C, et al.: Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol 2001, 23:167–175.

    Article  PubMed  CAS  Google Scholar 

  16. Reed RJ, Martin P: Variants of melanoma. Semin Cutan Med Surg 1997, 16:137–158.

    Article  PubMed  CAS  Google Scholar 

  17. Merot Y, Mihm MC: [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases.] Ann Dermatol Venereol 1985, 112:325–336.

    PubMed  CAS  Google Scholar 

  18. Chorny JA, Barr RJ, Kyshtoobayeva A, et al.: Ki-67 and p53 expression in minimal deviation lesions as compared with other nevomelanocytic lesions. Mod Pathol 2003, 16:525–529.

    Article  PubMed  Google Scholar 

  19. Levene A: Equine melanotic disease. Tumori 1971, 57:133–168.

    PubMed  CAS  Google Scholar 

  20. Rappaport H, Pietra G, Shubick P: The induction of melanotic tumors resembling cellular blue nevi in the Syrian hamster by cutaneous application of 7, 12-dimethylbenz-(a)-anthracene. Cancer Res 1961, 21:661–666.

    CAS  Google Scholar 

  21. Darier J: Le melanome malin mesenchymateaux ou melanosarcome. Bull Assoc Fr Cancer 1925, 14:221–249.

    Google Scholar 

  22. Crowson AN, Magro CM, Mihm MC Jr: Malignant melanoma with prominent pigment synthesis: “animal type” melanoma. Hum Pathol 1999, 30:543–550.

    Article  PubMed  CAS  Google Scholar 

  23. Kopf AW, Bart RS. Malignant blue (Ota’s?) news. J Dermatol Surg Oncol 1982, 8:442–445.

    PubMed  CAS  Google Scholar 

  24. Van Krieken JH, Boom BW, Scheffer E. Malignant transformation in a naevus of Ito: a case report. Histopathology 12(1):100–102, 1988 Jan.

    PubMed  Google Scholar 

  25. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004, 28:31–40.

    Article  PubMed  Google Scholar 

  26. Zembowicz A, Mihm MC: Pigment synthesizing melanocytic tumor: A low grade melanocytic tumor with frequent lymph node metastases [abstract]. Lab Invest 2002, 82:112A.

    Google Scholar 

  27. Allen AC, Spitz S: Malignant melanoma: a clinicopathologic analysis of the criteria for diagnosis and prognosis. Cancer 1953, 6:1–45.

    Article  PubMed  CAS  Google Scholar 

  28. Temple-Camp CRE, Saxe N, King H: Benign and malignant cellular blue nevus: a clinicopathological study of 30 cases. Am J Dermatopathol 1988, 10: 289–296.

    Article  PubMed  CAS  Google Scholar 

  29. Ozgur F, Akyurek M, Kayikcioglu A, et al.: Metastatic malignant blue nevus: a case report. Ann Plast Surg 1997, 39:411–415.

    Article  PubMed  CAS  Google Scholar 

  30. Ariyanayagam-Baksh SM, Baksh FK, Finkelstein SD, et al.: Malignant blue nevus. A case report and molecular analysis. Am J Dermatopathol 2003, 25:21–7.

    Article  PubMed  Google Scholar 

  31. Nödl F, Krüger R: Maligner blauer Navus bei Navus Ota. Hautartz 1984, 35:421–424.

    Google Scholar 

  32. Yoneyama K, Kamada N, Mizoguchi M, et al.: Malignant melanoma and acquired dermal melanocytosis on congenital nevus spilus. J Dermatol 2005, 32:454–8.

    PubMed  Google Scholar 

  33. Avidor I, Kessler E: “Atypical” blue nevus-a benign variant of cellular blue nevus. Presentation of three cases. Dermatologica 1977, 154:39–44.

    PubMed  CAS  Google Scholar 

  34. Sterchi JM, Muss HB, Weidner N: Cellular blue nevus simulating metastatic melanoma: report of an unusually large lesion associated with nevus-cell aggregates in regional lymph nodes. J Surg Oncol 1987, 36:71–75.

    Article  PubMed  CAS  Google Scholar 

  35. Grunwald MH, Rothem A, Feuerman EJ: Metastatic malignant melanoma with cartilaginous metaplasia. Dermatologica 1985, 170:249–252.

    Article  PubMed  CAS  Google Scholar 

  36. Toda S, Heasley DD, Mihm MC: Osteogenic melanoma: stromal metaplasia in association with subungual melanoma. Histopathology 1997, 31:293–295.

    PubMed  CAS  Google Scholar 

  37. Hendrickson MR, Ross JC: Neoplasms arising in congenital giant nevi: morphological study of seven cases and a review of the literature. Am J Surg Pathol 1981, 5:109–135.

    PubMed  CAS  Google Scholar 

  38. Perniciaro C: Dermatopathologic variants of malignant melanoma. Mayo Clin Proc 1997, 72:273–279.

    PubMed  CAS  Google Scholar 

  39. Kao GF, Helwig EB, Graham JH: Balloon cell malignant melanoma of the skin. A clinicopathologic study of 34 cases with histochemical, immunohistochemical, and ultrastructural observations. Cancer 1992, 69:2942–2952.

    Article  PubMed  CAS  Google Scholar 

  40. Perez MT, Suster S: Balloon cell change in cellular blue nevus. Am J Dermatopathol 1999, 21:181–184.

    Article  PubMed  CAS  Google Scholar 

  41. Martinez F, Merenda G, Bedrossian CW: Lipid-rich metastatic balloon-cell melanoma: diagnosis by a multimodal approach to aspiration biopsy cytology. Diagn Cytopathol 1990, 6:427–433.

    Article  PubMed  CAS  Google Scholar 

  42. Nakleh RE, Wick MR, Rocamora A, et al.: Morphological diversity in malignant melanomas. Am J Clin Pathol 1990, 93:731–840.

    Google Scholar 

  43. Neimann TH, Thomas PA: Melanoma with signet-ring cells in a peritoneal effusion. Diagn Cytopathol 1995, 12:241–244.

    Article  Google Scholar 

  44. Eckert F, Baricevic B, Landthaler M, Schmid U: Metastatic signet-ring melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical and ultrastructural findings. J Am Acad Dermatol 1992, 26:870–875.

    Article  PubMed  CAS  Google Scholar 

  45. Hanna W, Kahn HJ, From L: Signet ring lymphoma of the skin: ultrastructural and immunohistochemical features. J Am Acad Dermatol 1986, 14:344–350.

    Article  PubMed  CAS  Google Scholar 

  46. LiVolsi VA, Brooks JJ, Soslow R, et al.: Signet ring melanocytic lesions. Mod Pathol 1992, 5:515–520.

    PubMed  CAS  Google Scholar 

  47. Collina G, Losi L, Taccagni GL, Maiorana A: Myxoid metastases of melanoma: report of three cases and review of the literature. Am J Dermatopathol 1997, 19:52–57.

    Article  PubMed  CAS  Google Scholar 

  48. Nottingham JF, Slater DN: Malignant melanoma: a new mimic of colloid adenocarcinoma. Histopathology 1988, 13:576–578.

    Article  PubMed  CAS  Google Scholar 

  49. Zelger BG, Steiner H, Wambacher B, Zelger B: Malignant melanomas simulating various types of soft tissue tumors. Dermatol Surg 1997, 23:1047–1054.

    Article  PubMed  CAS  Google Scholar 

  50. Hitchcock MG, McCalmont TH, White WL: Cutaneous melanoma with myxoid features. Am J Surg Pathol 1999, 23:1506–1513.

    Article  PubMed  CAS  Google Scholar 

  51. Chetty R, Slavin JL, Pitson GA, Dowling JP: Melanoma botryoides: a distinctive myxoid pattern of sino-nasal melanoma. Histopathology 1994, 24:377–379.

    Article  PubMed  CAS  Google Scholar 

  52. Rocamora A, Carrillo R, Vives R, Solera JC: Fine needle aspiration biopsy of myxoid metastasis of malignant melanonma. Acta Cytol 1988, 32:94–100.

    PubMed  CAS  Google Scholar 

  53. Kim YC, Vandersteen DP, Juang HG: Myxoid clear cell sarcoma. Am J Dermatopathol 2005, 27:51–55.

    Article  PubMed  Google Scholar 

  54. LaMar WL, Crowson AN: Malignant melanoma with prominent myxoid stroma (“myxoid melanoma”). Melanoma Res 2001, 11(Suppl 1):S58.

    Google Scholar 

  55. Patel SR, Burgess MA, Plager C, et al.: Myxoid liposarcoma. Experience with chemotherapy. Cancer 1994, 74:1265–1269.

    Article  PubMed  CAS  Google Scholar 

  56. Patel SR, Plager C, Papadopoulos NE, Benjamin RS: Myxoid malignant fibrous histiocytoma: experience with chemotherapy. Am J Clin Oncol 1995, 18:528–531.

    Article  PubMed  CAS  Google Scholar 

  57. Shidham VB, Ayala GE, Lahaniatis JE, Garcia FU: Low grade fibromyxoid sarcoma: clinicopathologic case report with review of the literature. Am J Clin Oncol 1999, 22:150–155.

    Article  PubMed  CAS  Google Scholar 

  58. Mentzel T, Dry S, Katenkamp D, Fletcher CDM: Low grade myofibroblastic sarcoma. Analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol 1998, 22:1228–1238.

    Article  PubMed  CAS  Google Scholar 

  59. Meiss-Kindblom JM, Bergh P, Gunterberg B, Kindblom LG: Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphological spectrum and prognostic factors based upon 117 cases. Am J Surg Pathol 1999, 23:636–650.

    Article  Google Scholar 

  60. Bhuta S, Mirra J, Cochran A: Myxoid malignant melanoma. A previously undescribed histologic pattern noted in metastatic lesions and a report of four cases. Am J Surg Pathol 1986, 10:203–211.

    Article  PubMed  CAS  Google Scholar 

  61. Hinze P, Feyler S, Berndt J, Knolle J, Katenkamp D: Malignant myoepithelioma of the vulva resembling arhabdoid tumour. Histopathology 1999, 35:50–54.

    Article  PubMed  CAS  Google Scholar 

  62. Krane JF, Bertoni F, Fletcher CD: Myxoid synovial sarcoma: an underappreciated morphological subset. Mod Pathol 1999, 12:456–462.

    PubMed  CAS  Google Scholar 

  63. Orlandi A, Bianchi L, Spagnoli LG: Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. J Cutan Pathol 1998, 25:386–393.

    Article  PubMed  CAS  Google Scholar 

  64. Chan JK, Buchanan R, Fletcher CD: Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. Am J Surg Pathol 1990, 14:983–988.

    Article  PubMed  CAS  Google Scholar 

  65. Abbott JJ, Amirkhan RH, Hong MP: Malignant melanoma with a rhabdoid phenotype: histologic, immunohistochemical, and ultrastructural study of a case and review of the literature. Arch Pathol Lab Med 2004, 128:686–688.

    PubMed  Google Scholar 

  66. Borek B, McKee P, Freeman J, et al.: Primary malignant melanoma with rhabdoid features: A histologic and immunocytochemical study of three cases. Am J Dermatopathol 1998, 20:123–127.

    Article  PubMed  CAS  Google Scholar 

  67. Thomas, JM, Newton-Bishop J, A’Hearn, R, et al.: Excision margins in high-risk malignant melanoma. N Engl J Med 2004, 350:757–766.

    Article  PubMed  CAS  Google Scholar 

  68. Naylor MF, Crowson N, Kuwahara R, et al.: Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 2003, 149(Suppl 66):66–69.

    Article  PubMed  CAS  Google Scholar 

  69. Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol 2000, 7:160–165.

    Article  PubMed  CAS  Google Scholar 

  70. Zettersten E, Sagebiel RW, Miller JR III, et al.: Prognostic factors in patients with thick cutaneous melanoma (> 4 mm). Cancer 2002, 94:1049–1056.

    Article  PubMed  Google Scholar 

  71. Cherpelis BS, Haddad F, Messina J, et al.: Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol 2001, 44:762–766.

    Article  PubMed  CAS  Google Scholar 

  72. Massi D, Franchi A, Borgognoni L, et al.: Thin cutaneous malignant melanoma (< or =1.5 mm): identification of risk factors indicative of progression. Cancer 1999, 85:1067–1076.

    Article  PubMed  CAS  Google Scholar 

  73. Dessureault S, Soong SJ, Ross MI: Improved staging of node-negative patients with intermediate to thick (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 2001, 8:766–770.

    Article  PubMed  CAS  Google Scholar 

  74. Morton DL, Thompson JF, Cochran AL, et al.: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355:1307–1317.

    Article  PubMed  CAS  Google Scholar 

  75. Balch CM, Cascinelli NF: Sentinel-node biopsy in melanoma. N Engl J Med 2006, 355:1370–1371.

    Article  PubMed  CAS  Google Scholar 

  76. Gyorki DE, Busam K, Panageas K, et al.: Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 2003, 10:403–407.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Neil Crowson MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crowson, A.N., Magro, C. & Mihm, M.C. Unusual histologic and clinical variants of melanoma: Implications for therapy. Curr Oncol Rep 9, 403–410 (2007). https://doi.org/10.1007/s11912-007-0055-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-007-0055-7

Keywords

Navigation